Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹95,319 Cr
Revenue (TTM)
₹8,140 Cr
Net Profit (TTM)
₹1,419 Cr
ROE
12.2 %
ROCE
14.7 %
P/E Ratio
67.2
P/B Ratio
9.2
Industry P/E
44.5
EV/EBITDA
42.2
Div. Yield
0.2 %
Debt to Equity
0.3
Book Value
₹106.4
EPS
₹15
Face value
10
Shares outstanding
973,135,041
CFO
₹4,889.53 Cr
EBITDA
₹6,461.93 Cr
Net Profit
₹3,687.56 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Max Healthcare
| -6.2 | -9.0 | -5.0 | -1.8 | 28.7 | 37.2 | -- |
|
BSE Sensex
| -9.4 | -8.1 | -9.3 | 3.4 | 9.8 | 9.0 | 12.0 |
|
BSE Healthcare
| -1.7 | -1.1 | -1.9 | 7.5 | 25.6 | 15.6 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Max Healthcare
| -8.3 | 63.9 | 56.1 | -0.8 | 210.8 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Max Healthcare
|
979.8 | 95,318.6 | 8,140.3 | 1,419.2 | 21.2 | 15 | 67.2 | 9.2 |
| 7,471.0 | 1,07,392.0 | 24,215.2 | 1,820.5 | 11.0 | 21 | 59.6 | 11.2 | |
| 662.0 | 34,286.7 | 4,461.2 | 397.5 | 13.4 | 9.1 | 104.9 | 7.5 | |
| 434.0 | 13,736.8 | 1,976.2 | 160.7 | 14.1 | 6.7 | 109 | 7.0 | |
| 846.0 | 63,843.0 | 8,770.4 | 966.3 | 17.8 | 11 | 66.5 | 6.6 | |
| 570.0 | 8,470.7 | 2,478.2 | 24.7 | 8.4 | 4.2 | 447 | 6.3 | |
| 1,282.0 | 8,393.4 | 1,433.4 | 188.7 | 17.4 | 13.8 | 44.5 | 5.6 | |
| 1,690.0 | 34,538.0 | 6,777.7 | 782.9 | 16.1 | 21.5 | 44.3 | 8.2 | |
| 1,123.9 | 11,410.7 | 1,613.3 | 259.9 | 23.0 | 17.3 | 44.3 | 7.2 | |
| 673.3 | 6,489.5 | 1,089.4 | 165.1 | 17.4 | 10.2 | 38.8 | 3.7 |
No Review & Analysis are available.
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including bariatric surgery/metabolic, bone marrow transplant, cancer/oncology, cardiac science, endocrinology and... diabetes, eye care, gastroenterology, hepatology and endoscopy, kidney transplant, laparoscopic, liver transplant, neuro science, orthopedics, robotic surgery, urology, and vascular surgery. The company provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres in Delhi and National Capital Region, Maharashtra, Punjab, Uttar Pradesh, and Uttarakhand. The company was incorporated in 2001 and is based in Gurugram, India. Read more
Incorporated
2001
Chairman
Abhay Soi
Managing Director
Abhay Soi
Group
Max
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Max Healthcare Institute Ltd is ₹979.80 (NSE) and ₹979.50 (BSE) as of 18-Mar-2026 IST. Max Healthcare Institute Ltd has given a return of 28.66% in the last 3 years.
The P/E ratio of Max Healthcare Institute Ltd is 67.16 times as on 18-Mar-2026, a 51 premium to its peers’ median range of 44.50 times.
The P/B ratio of Max Healthcare Institute Ltd is 9.20 times as on 18-Mar-2026, a 39 premium to its peers’ median range of 6.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
99.10
|
11.51
|
|
2024
|
75.39
|
9.56
|
|
2023
|
38.80
|
5.81
|
|
2022
|
55.59
|
5.37
|
|
2021
|
0.00
|
3.55
|
The 52-week high and low of Max Healthcare Institute Ltd are Rs 1,314.30 and Rs 933.80 as of 19-Mar-2026.
Max Healthcare Institute Ltd has a market capitalisation of ₹ 95,319 Cr as on 18-Mar-2026. As per SEBI classification, it is a Large Cap company.
Before investing in Max Healthcare Institute Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹3.40
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.